JP2009520480A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520480A5
JP2009520480A5 JP2008546287A JP2008546287A JP2009520480A5 JP 2009520480 A5 JP2009520480 A5 JP 2009520480A5 JP 2008546287 A JP2008546287 A JP 2008546287A JP 2008546287 A JP2008546287 A JP 2008546287A JP 2009520480 A5 JP2009520480 A5 JP 2009520480A5
Authority
JP
Japan
Prior art keywords
polypeptide
dimer
polypeptide dimer
monomer
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008546287A
Other languages
English (en)
Japanese (ja)
Other versions
JP5390191B2 (ja
JP2009520480A (ja
Filing date
Publication date
Priority claimed from EP05028420A external-priority patent/EP1801121A1/en
Application filed filed Critical
Publication of JP2009520480A publication Critical patent/JP2009520480A/ja
Publication of JP2009520480A5 publication Critical patent/JP2009520480A5/ja
Application granted granted Critical
Publication of JP5390191B2 publication Critical patent/JP5390191B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008546287A 2005-12-23 2006-12-22 医薬として有用な可溶性gp130分子変異体 Active JP5390191B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05028420.7 2005-12-23
EP05028420A EP1801121A1 (en) 2005-12-23 2005-12-23 Soluble gp130 molecule variants useful as a medicament
PCT/EP2006/012515 WO2007071449A1 (en) 2005-12-23 2006-12-22 Soluble gp130 molecule variants useful as a medicament

Publications (3)

Publication Number Publication Date
JP2009520480A JP2009520480A (ja) 2009-05-28
JP2009520480A5 true JP2009520480A5 (https=) 2010-01-21
JP5390191B2 JP5390191B2 (ja) 2014-01-15

Family

ID=36233865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546287A Active JP5390191B2 (ja) 2005-12-23 2006-12-22 医薬として有用な可溶性gp130分子変異体

Country Status (9)

Country Link
US (1) US7851182B2 (https=)
EP (2) EP1801121A1 (https=)
JP (1) JP5390191B2 (https=)
AT (1) ATE471945T1 (https=)
AU (1) AU2006328909A1 (https=)
CA (1) CA2633213A1 (https=)
DE (1) DE602006015103D1 (https=)
ES (1) ES2347694T3 (https=)
WO (1) WO2007071449A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2352561T3 (es) 2006-06-30 2011-02-21 Conaris Research Institute Ag Dímeros de sgp 130fc mejorados.
EP2174667B1 (en) * 2007-07-26 2017-01-04 Osaka University Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient
EP2050759A1 (en) 2007-10-19 2009-04-22 CONARIS research institute AG Soluble gp 130 muteins with improved binding activity
DK3227325T3 (da) 2014-12-01 2024-07-08 Ferring Bv Sammensætninger med selektive hæmmere af il-6-trans-signalering
HRP20210737T1 (hr) 2014-12-01 2021-06-11 Ferring B.V. Primjena selektivnog inhibitora il-6-trans-signalizacije
US20190002915A1 (en) * 2015-12-14 2019-01-03 The Trustees Of The University Of Pennsylvania Compositions and methods for regulatable antibody expression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
EP1115866A1 (en) * 1998-09-22 2001-07-18 University of Maryland at Baltimore Cystine knot growth factor mutants
HUP0105090A2 (hu) * 1999-01-07 2002-04-29 Lexigen Pharmaceuticals Corporation Kóros elhízás elleni fehérjék expressziója és exportja Fc fúziós fehérje formájában
ES2298106T3 (es) * 2000-04-21 2008-05-16 Conaris Research Institute Ag Proteinas de fusion que comprenden dos moleculas gp130 solubles.
AU2002337920A1 (en) * 2001-10-19 2003-04-28 Zymogenetics, Inc. Dimerized growth factor and materials and methods for producing it
EP1491554A1 (en) * 2003-06-23 2004-12-29 CONARIS research institute AG PEGylated soluble gp130-dimers useful as a medicament
BRPI0507174A (pt) * 2004-01-28 2008-04-01 Syntonix Pharmaceuticals Inc proteìnas de fusão hormÈnio-fc (fsh-fc) heterodiméricas estimuladoras de folìculo para o tratamento da infertilidade

Similar Documents

Publication Publication Date Title
US8669350B2 (en) TNF receptor Fc fusion proteins and in vivo methods of use
JP2023520922A5 (https=)
JP2023058590A5 (https=)
JP2010519293A5 (https=)
JP2004503213A5 (https=)
JP2014503198A5 (https=)
JP2023503868A5 (https=)
JP2020500015A5 (https=)
JP2013513377A5 (https=)
JP2003530070A5 (https=)
JP2012522529A5 (https=)
JP2015508077A5 (https=)
JP2015504675A5 (https=)
JP2008507298A5 (https=)
JP2005523681A5 (https=)
CN102898526A (zh) 一种肿瘤坏死因子相关凋亡诱导配体融合蛋白及其制备和应用
CN114133435B (zh) 一种类弹性蛋白多肽及应用
JP2018537089A5 (https=)
JP2020517260A5 (https=)
JP2008509682A5 (https=)
JP2009520480A5 (https=)
JP2014517690A5 (https=)
JP2009509553A5 (https=)
IL209595A (en) Isolated nucleic acid, expression vector and host cell containing it, isolated polypeptide encoded by it and chimeric polypeptide containing it, process for preparation, oligopeptide hhipl l2 mimics loop, preparations containing it and methods for its production
EP2361262A1 (en) Tetranectin trimeri zing module truncation variants